Our purpose
Improving people’s lives and health outcomes by focusing on areas of high unmet medical need, we are accelerating our momentum and rapidly boosting our pipeline to bring the full potential of our innovative medicines to patients
Learn moreMaking a Difference Where it s Needed Most
Neuroscience
people worldwide live with spasticity, yet access to treatment remains limited
Rare Diseases
people globally are living with a rare disease most with no approved treatment
Oncology
people die from cancer every year, making it a leading global killer
Underserved Population
of rare diseases begin in childhood yet most go undiagnosed or untreated
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Latest highlights
Find out what’s been going on at Ipsen of late – with press releases, trending stories, events, and more
How Ipsen helps
Ipsen focuses on three key therapeutic areas, leveraging all our resources to help patients with unmet medical needs
Oncologie
Ipsen has been working in oncology since 1986, and now has a portfolio that includes treatments for neuroendocrine tumor (NETs), and cancers of the kidney, liver, pancreas, thyroid, prostate and breast.
Maladies Rares
Ninety-four percent of rare medical conditions still have no treatment. We are committed to finding treatments for extremely rare bone diseases and disorders, growth disorders, rare cancers, rare liver disease and rare neurogenetic disorders.
Neurosciences
Ipsen draws on 30 years of expertise in toxins and neuroscience research to support children and adults suffering from debilitating and degenerative neurological conditions.